Author: Yoshiyama, Takashi; Saito, Yasuki; Masuda, Kunitsugu; Nakanishi, Yoshiko; Kido, Yasutoshi; Uchimura, Kazuhiro; Mitarai, Satoshi; Suzuki, Tadaki; Nakagama, Yu; Kubota, Hiroshi; Satomi, Maki; Uchikoba, Sana; Ohnishi, Makoto; Wakita, Takaji; Kato, Seiya; Kato, Katsunobu
Title: Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020 Cord-id: khue3b4g Document date: 2021_2_25
ID: khue3b4g
Snippet: We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.
Document: We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.
Search related documents:
Co phrase search for related documents- abbott test and low prevalence setting: 1
- accurate surveillance and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
- accurate surveillance and low prevalence setting: 1
- acute respiratory syndrome coronavirus and low prevalence area: 1, 2, 3, 4
- acute respiratory syndrome coronavirus and low prevalence setting: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute respiratory syndrome coronavirus and low response rate: 1, 2
Co phrase search for related documents, hyperlinks ordered by date